This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Jan 1;110(1).

doi: 10.1093/jnci/djx143.

Searching for the IDEAL Duration of Adjuvant Endocrine Therapy

Rachel L Yung¹, Nancy E Davidson¹

Affiliations

PMID: 28922788
DOI: 10.1093/jnci/djx143

Comment

Searching for the IDEAL Duration of Adjuvant Endocrine Therapy

Rachel L Yung et al. J Natl Cancer Inst. 2018.

. 2018 Jan 1;110(1).

doi: 10.1093/jnci/djx143.

Authors

Rachel L Yung¹, Nancy E Davidson¹

Affiliation

¹ Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle Cancer Care Alliance, Seattle, WA.

PMID: 28922788
DOI: 10.1093/jnci/djx143

No abstract available

PubMed Disclaimer

Comment on

Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).
Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, van den Bosch J, Maartense E, van Leeuwen-Stok AE, Liefers GJ, Nortier JWR, Rutgers EJT, van de Velde CJH; IDEAL Study Group. Blok EJ, et al. J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx134. J Natl Cancer Inst. 2018. PMID: 28922787 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information